Executive Summary
The July 7, 2026 insider trading digest reveals a mixed landscape with notable insider selling at Cellebrite, Dexcom, and Privia Health, while significant insider buying and warrant acquisitions at Meridian3 Industrials Acquisition Corp signal strong conviction in a SPAC deal.
Period-over-period trends are limited due to the nature of Form 4 filings, but the aggregate data shows a net selling bias among executives, with over $7.5M in sales versus minimal open-market purchases. Key themes include tax-related stock withholding at Incyte and EchoStar, option exercises at Inmune Bio, and a flurry of director awards at Par Pacific Holdings. The most critical development is the coordinated insider buying of private placement warrants at Meridian3, suggesting a high-conviction bet on a near-term business combination. Investors should monitor the high-volume sales at Cellebrite and Dexcom for potential bearish signals, while the insider activity at Inmune Bio and Par Pacific indicates underlying confidence.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior Insider Trading Pulse digest from July 06, 2026.
Investment Signals (11)
- Meridian3 Industrials Acquisition Corp ↓ (BULLISH)▲
CEO and Director acquired $3.75M each in private placement warrants at $1.00, with simultaneous restructuring of founder shares, indicating strong insider conviction in the SPAC's target
- Cellebrite DI Ltd. ↓ (BEARISH)▲
CEO sold $1.63M of shares at $15.76, representing a significant 14.9% reduction in holdings, suggesting potential overvaluation or insider caution
- Dexcom Inc ↓ (BEARISH)▲
Executive Chair sold $1.93M of stock at $72.00 under a 10b5-1 plan, the largest single insider sale in the digest, which may signal a top in the stock
- Privia Health Group ↓ (BEARISH)▲
Director sold $1.61M of stock at $27.33 after exercising options at $2.00, realizing a 13.7x gain, which could indicate a lack of confidence in near-term upside
- Inmune Bio Inc ↓ (BULLISH)▲
CEO exercised 9,014 warrants at $0.13 and converted to common stock at $1.40, increasing his stake by 0.7%, showing alignment with shareholders
-
EVP sold $800K of stock at $519.00 under a 10b5-1 plan, a modest sale relative to total holdings but notable given the high stock price [NEUTRAL/BEARISH]
- Sony Group Corp ↓ (BEARISH)▲
CSO sold $526K of stock at $21.02, a routine diversification but worth monitoring given the size
- Par Pacific Holdings ↓ (BULLISH)▲
Multiple directors acquired shares via RSU vesting and open-market purchases at ~$58.49, with aggregate insider buying of ~$140K, signaling board-level confidence
- Alpha Tau Medical ↓ (NEUTRAL)▲
CFO sold $31.8K of stock at $14.00 after exercising options at $2.98, a 4.7x gain, but the sale is small relative to holdings
- Quantum Corp ↓ (BEARISH)▲
CEO sold $65.5K and CAO sold $2.73K of stock at $10.51, representing a 5% reduction for the CEO, which may signal near-term headwinds
- Incyte Corp ↓ (NEUTRAL)▲
CEO had $558K in shares withheld for taxes, a routine transaction but the large dollar amount reflects significant equity compensation
Risk Flags (8)
- Cellebrite/CEO Selling↓ [HIGH RISK]▼
CEO Hogan sold 103,188 shares ($1.63M), reducing his stake by 14.9%, which is a significant insider divestment that could indicate upcoming challenges
- Dexcom/Executive Chair Selling↓ [HIGH RISK]▼
Executive Chair Sayer sold 26,756 shares ($1.93M) under a 10b5-1 plan, the largest sale in the digest, potentially signaling a peak in the stock
- Privia Health/Director Selling↓ [HIGH RISK]▼
Director Morris sold 59,037 shares ($1.61M) after exercising cheap options, realizing a massive gain and reducing his stake by 46.4%, suggesting limited confidence
- Vertex/EVP Selling↓ [MEDIUM RISK]▼
EVP McKechnie sold 1,541 shares ($800K) at $519, a high-price sale that could indicate the stock is fully valued
- Sony/CSO Selling↓ [MEDIUM RISK]▼
CSO Mitomo sold 25,000 shares ($526K), a large sale for a non-CEO executive that warrants monitoring for further insider activity
- Quantum/CEO Selling↓ [MEDIUM RISK]▼
CEO Meyrath sold 6,232 shares ($65.5K), a 5% reduction in holdings, which combined with the CAO sale suggests insider pessimism
- Miami International Holdings/Director Selling↓ [MEDIUM RISK]▼
Two directors sold a combined $327K under 10b5-1 plans, indicating a pattern of insider profit-taking
- Alpha Tau/CFO Selling↓ [LOW RISK]▼
CFO sold 2,270 shares after exercising options, a small sale but notable as the only insider transaction in the filing
Opportunities (8)
- Meridian3 Industrials Acquisition Corp/Warrant Buying↓ (OPPORTUNITY)◆
Insiders acquired $11.5M in private placement warrants at $1.00, signaling a high-conviction bet on a successful de-SPAC; warrants offer leveraged upside
- Inmune Bio/Insider Exercise↓ (OPPORTUNITY)◆
CEO and CSO exercised warrants at $0.13 and converted to common stock, increasing their stakes; with the stock at $1.40, this shows insider confidence in the company's pipeline
- Par Pacific Holdings/Director Buying↓ (OPPORTUNITY)◆
Multiple directors acquired shares at $58.49 via RSU vesting and open-market purchases, with aggregate insider buying of ~$140K, indicating board-level confidence in the company's outlook
- EchoStar/Director Option Exercise↓ (OPPORTUNITY)◆
Director Hershman exercised 10,000 options at $24.49 and held the stock, showing confidence despite tax withholding; the stock trades at $100.88, a 4.1x gain
- Belden/EVP Purchase↓ (OPPORTUNITY)◆
EVP Anderson acquired 213 shares at $99.65, a small but positive insider purchase that could signal undervaluation
- Texas Pacific Land/10% Owner Purchase↓ (OPPORTUNITY)◆
Horizon Kinetics bought 1 share at $408.89, a token purchase but from a sophisticated investor, potentially signaling a floor
- Monarch Casino/Director Award↓ (OPPORTUNITY)◆
Director Taitz was awarded 6,100 options at $131.61 ($803K value), aligning director interests with shareholders and suggesting long-term value
- IMMUNIC/Director Awards↓ (OPPORTUNITY)◆
Three directors were awarded 25,370 stock options each, totaling 76,110 options, indicating strong board alignment with the company's future
Sector Themes (5)
- SPAC Insider Conviction (HIGH CONVICTION)◆
Meridian3 Industrials Acquisition Corp saw $11.5M in insider warrant purchases, indicating strong belief in the SPAC's target; this contrasts with typical SPAC insider selling
- Biotech Insider Confidence (BULLISH)◆
Inmune Bio and IMMUNIC insiders exercised warrants and accepted option awards, showing confidence in pipeline value despite sector volatility
- Tech Insider Selling Pressure (BEARISH)◆
Cellebrite, Dexcom, Sony, and Vertex insiders sold over $4.8M combined, suggesting a bearish tilt in the tech sector at current valuations
- Energy/Industrial Insider Stability (BULLISH)◆
Par Pacific Holdings and Belden saw insider buying, while EchoStar directors exercised options, indicating relative confidence in these sectors
- Tax-Related Selling Dominates (NEUTRAL)◆
Multiple filings (Incyte, EchoStar) involve shares withheld for taxes, which are non-discretionary and should not be interpreted as bearish signals
Watch List (8)
- 👁
Monitor for announcement of a business combination target; insider warrant buying at $1.00 suggests a deal is imminent
- Cellebrite DI Ltd.↓ (WATCH)👁
CEO sold 14.9% of holdings; watch for further insider sales or guidance changes that could confirm bearish sentiment
- Dexcom Inc↓ (WATCH)👁
Executive Chair sold $1.93M under 10b5-1; monitor next earnings call for any downward guidance revision
- Privia Health Group↓ (WATCH)👁
Director sold 46.4% of stake; watch for additional insider sales or changes in company fundamentals
- Inmune Bio Inc↓ (WATCH)👁
Insider warrant exercises suggest confidence; watch for clinical trial updates or partnership announcements
- Vertex Pharmaceuticals↓ (WATCH)👁
EVP sold $800K at $519; monitor for any pipeline setbacks or competitive threats
- Sony Group Corp↓ (WATCH)👁
CSO sold $526K; watch for further insider selling that could indicate a broader trend
- Quantum Corp↓ (WATCH)👁
CEO and CAO sold shares; monitor for any operational challenges or earnings misses
Filing Analyses
(50)
07-07-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
07-07-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
07-07-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
07-07-2026
Director O'Rourke Peter was awarded 112,859 Stock Option (Right to Buy).
- · Director O'Rourke Peter was awarded 112,859 Stock Option (Right to Buy)
07-07-2026
Director ERGEN CANTEY had withheld for taxes 17 Class A Common Stock at $100.88 (~$1.71K). ERGEN CANTEY holds 2,148 shares after the transaction.
- · Director ERGEN CANTEY was awarded 198 Class A Common Stock
- · Director ERGEN CANTEY had withheld for taxes 17 Class A Common Stock at $100.88 (~$1.71K)
07-07-2026
EVP, Chief Financial Officer ORBAN PAUL W had withheld for taxes 9 Class A Common Stock at $100.88 (~$908). ORBAN PAUL W holds 50,934 shares after the transaction.
- · EVP, Chief Financial Officer ORBAN PAUL W was awarded 297 Class A Common Stock
- · EVP, Chief Financial Officer ORBAN PAUL W had withheld for taxes 9 Class A Common Stock at $100.88 (~$908)
07-07-2026
Director Hershman Lisa W. had withheld for taxes 2,428 Class A Common Stock at $100.88 (~$245K). Hershman Lisa W. holds 7,572 shares after the transaction.
- · Director Hershman Lisa W. exercised/converted 10,000 Class A Common Stock at $24.49 (~$245K)
- · Director Hershman Lisa W. had withheld for taxes 2,428 Class A Common Stock at $100.88 (~$245K)
- · Director Hershman Lisa W. exercised/converted 10,000 Non-Employee Director Stock Option
07-07-2026
Director Dodge R Stanton had withheld for taxes 1,214 Class A Common Stock at $100.88 (~$122K). Dodge R Stanton holds 25,341 shares after the transaction.
- · Director Dodge R Stanton exercised/converted 5,000 Class A Common Stock at $24.49 (~$122K)
- · Director Dodge R Stanton had withheld for taxes 1,214 Class A Common Stock at $100.88 (~$122K)
- · Director Dodge R Stanton exercised/converted 5,000 Non-Employee Director Stock Option
07-07-2026
Director DEFRANCO JAMES had withheld for taxes 16 Class A Common Stock at $100.88 (~$1.61K). DEFRANCO JAMES holds 1,870 shares after the transaction.
- · Director DEFRANCO JAMES was awarded 198 Class A Common Stock
- · Director DEFRANCO JAMES had withheld for taxes 16 Class A Common Stock at $100.88 (~$1.61K)
07-07-2026
Director Clossey Timothy was awarded 470 Common stock at $58.49 (~$27.5K). Clossey Timothy holds 75,932 shares after the transaction.
- · Director Clossey Timothy was awarded 470 Common stock at $58.49 (~$27.5K)
07-07-2026
Chief Executive Officer Moss David J exercised/converted 9,014 Common Stock at $1.40 (~$12.6K). Moss David J holds 1,294,883 shares after the transaction.
- · Chief Executive Officer Moss David J exercised/converted 9,014 Common Stock at $1.40 (~$12.6K)
- · Chief Executive Officer Moss David J exercised/converted 9,014 Common Stock Purchase Warrant at $0.13 (~$1.13K)
07-07-2026
Chief Scientific Officer Lowdell Mark William exercised/converted 7,211 Common Stock at $1.40 (~$10.1K). Lowdell Mark William holds 1,518,017 shares after the transaction.
- · Chief Scientific Officer Lowdell Mark William exercised/converted 7,211 Common Stock at $1.40 (~$10.1K)
- · Chief Scientific Officer Lowdell Mark William exercised/converted 7,211 Common Stock Purchase Warrant at $0.13 (~$901)
07-07-2026
Director Juda Scott exercised/converted 14,801 Common Stock at $1.40 (~$20.7K). Juda Scott holds 86,404 shares after the transaction.
- · Director Juda Scott exercised/converted 14,801 Common Stock at $1.40 (~$20.7K)
- · Director Juda Scott exercised/converted 14,801 Common Stock Purchase Warrant at $0.13 (~$1.85K)
07-07-2026
Director ANASTASIO CURT acquired 507 Common Stock at $58.49 (~$29.7K). ANASTASIO CURT holds 111,697 shares after the transaction.
- · Director ANASTASIO CURT acquired 507 Common Stock at $58.49 (~$29.7K)
- · Director ANASTASIO CURT was awarded 470 Common Stock at $58.49 (~$27.5K)
- · Director ANASTASIO CURT exercised/converted 507 Restricted stock units
07-07-2026
Director Zell Aaron was awarded 470 Restricted stock units.
- · Director Zell Aaron was awarded 470 Restricted stock units
07-07-2026
Director YEAMAN ERIC K was awarded 470 Restricted stock units.
- · Director YEAMAN ERIC K was awarded 470 Restricted stock units
07-07-2026
Director PATE WILLIAM was awarded 470 Restricted stock units.
- · Director PATE WILLIAM was awarded 470 Restricted stock units
07-07-2026
Director Hatcher Katherine was awarded 470 Common stock at $58.49 (~$27.5K). Hatcher Katherine holds 40,415 shares after the transaction.
- · Director Hatcher Katherine was awarded 470 Common stock at $58.49 (~$27.5K)
07-07-2026
Director Leogrande Hudson Blake exercised/converted 2,000 Class A Ordinary Share, par value $0.0015 per share. Leogrande Hudson Blake holds 2,000 shares after the transaction.
- · Director Leogrande Hudson Blake exercised/converted 2,000 Class A Ordinary Share, par value $0.0015 per share
- · Director Leogrande Hudson Blake exercised/converted 2,000 Restricted Stock Unit
07-07-2026
Director SILBERMAN ROBERT S was awarded 1,026 Restricted stock units.
- · Director SILBERMAN ROBERT S was awarded 1,026 Restricted stock units
07-07-2026
Director Davidson Phillip S acquired 461 Common stock at $58.49 (~$27K). Davidson Phillip S holds 9,465 shares after the transaction.
- · Director Davidson Phillip S acquired 461 Common stock at $58.49 (~$27K)
- · Director Davidson Phillip S was awarded 470 Restricted stock units
- · Director Davidson Phillip S exercised/converted 461 Restricted stock units
07-07-2026
Director Martinez Patricia was awarded 470 Restricted stock units.
- · Director Martinez Patricia was awarded 470 Restricted stock units
07-07-2026
Chief Financial Officer Levy Raphi sold 2,270 Ordinary Shares at $14.00 (~$31.8K). Levy Raphi holds 90,180 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Financial Officer Levy Raphi exercised/converted 2,270 Ordinary Shares at $2.98 (~$6.76K)
- · Chief Financial Officer Levy Raphi sold 2,270 Ordinary Shares at $14.00 (~$31.8K)
07-07-2026
Chief Executive Officer Hogan Thomas E. sold 103,188 Ordinary shares, par value NIS 0.00001 at $15.76 (~$1.63M). Hogan Thomas E. holds 590,777 shares after the transaction.
- · Chief Executive Officer Hogan Thomas E. sold 103,188 Ordinary shares, par value NIS 0.00001 at $15.76 (~$1.63M)
07-07-2026
Director PHILLIPS BARCLAY A was awarded 25,370 Stock Option.
- · Director PHILLIPS BARCLAY A was awarded 25,370 Stock Option
07-07-2026
Director Kelley Elizabeth R acquired by will/inheritance 217 Common Stock. Kelley Elizabeth R holds 4,239 shares after the transaction.
- · Director Kelley Elizabeth R acquired by will/inheritance 217 Common Stock
07-07-2026
Chief Strategy Officer (CSO) Mitomo Toshimoto sold 25,000 Common Stock at $21.02 (~$526K). Mitomo Toshimoto holds 115,700 shares after the transaction.
- · Chief Strategy Officer (CSO) Mitomo Toshimoto sold 25,000 Common Stock at $21.02 (~$526K)
07-07-2026
VP and Chief Financial Officer Quigg Andrew J gifted 531 Common. Quigg Andrew J holds 39,095.185 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · VP and Chief Financial Officer Quigg Andrew J gifted 531 Common
07-07-2026
10% owner HORIZON KINETICS ASSET MANAGEMENT LLC bought 1 Common Stock at $408.89 (~$409). HORIZON KINETICS ASSET MANAGEMENT LLC holds 3,263,669 shares after the transaction.
- · 10% owner HORIZON KINETICS ASSET MANAGEMENT LLC bought 1 Common Stock at $408.89 (~$409)
07-07-2026
Director Rudick Richard Alan was awarded 25,370 Stock Option.
- · Director Rudick Richard Alan was awarded 25,370 Stock Option
07-07-2026
Director Bulley David Robert acquired 3,750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$3.75M). 5 transactions reported in total.
- · Director Bulley David Robert disposed of 2,381,250 Class B Ordinary Shares at $0.01 (~$11.9K)
- · Director Bulley David Robert acquired 793,750 Class B Ordinary Shares at $0.01 (~$3.97K)
- · Director Bulley David Robert acquired 3,750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$3.75M)
- · Director Bulley David Robert disposed of 750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$750K)
- · Director Bulley David Robert acquired 250,000 Private Placement Warrants (Right to Buy) at $1.00 (~$250K)
07-07-2026
Chief Executive Officer Mistry Faramaraz Jeremey acquired 3,750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$3.75M). 5 transactions reported in total.
- · Chief Executive Officer Mistry Faramaraz Jeremey disposed of 2,381,250 Class B Ordinary Shares at $0.01 (~$11.9K)
- · Chief Executive Officer Mistry Faramaraz Jeremey acquired 793,750 Class B Ordinary Shares at $0.01 (~$3.97K)
- · Chief Executive Officer Mistry Faramaraz Jeremey acquired 3,750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$3.75M)
- · Chief Executive Officer Mistry Faramaraz Jeremey disposed of 750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$750K)
- · Chief Executive Officer Mistry Faramaraz Jeremey acquired 250,000 Private Placement Warrants (Right to Buy) at $1.00 (~$250K)
07-07-2026
Director Taitz Hope S was awarded 6,100 Option/Right to Buy at $131.61 (~$803K).
- · Director Taitz Hope S was awarded 6,100 Option/Right to Buy at $131.61 (~$803K)
07-07-2026
Director Speth Ralf acquired 125,000 Private Placement Warrants (Right to Buy) at $1.00 (~$125K).
- · Director Speth Ralf acquired 396,875 Class B Ordinary Shares at $0.01 (~$1.98K)
- · Director Speth Ralf acquired 125,000 Private Placement Warrants (Right to Buy) at $1.00 (~$125K)
07-07-2026
EVP - Chief Legal Officer Anderson Brian Edward acquired 213 Common Stock at $99.65 (~$21.2K). Anderson Brian Edward holds 47,491 shares after the transaction.
- · EVP - Chief Legal Officer Anderson Brian Edward acquired 213 Common Stock at $99.65 (~$21.2K)
07-07-2026
Chief Investment Officer Berger Stefan acquired 125,000 Private Placement Warrants (Right to Buy) at $1.00 (~$125K).
- · Chief Investment Officer Berger Stefan acquired 396,875 Class B Ordinary Shares at $0.01 (~$1.98K)
- · Chief Investment Officer Berger Stefan acquired 125,000 Private Placement Warrants (Right to Buy) at $1.00 (~$125K)
07-07-2026
10% owner Meridian3 Partners Sponsor LLC acquired 3,750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$3.75M).
- · 10% owner Meridian3 Partners Sponsor LLC disposed of 2,381,250 Class B Ordinary Shares, par value $0.0001 per share at $0.01 (~$11.9K)
- · 10% owner Meridian3 Partners Sponsor LLC acquired 3,750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$3.75M)
- · 10% owner Meridian3 Partners Sponsor LLC disposed of 750,000 Private Placement Warrants (Right to Buy) at $1.00 (~$750K)
07-07-2026
Chief Financial Officer FOSTER JEFFREY H acquired 125,000 Private Placement Warrants (Right to Buy) at $1.00 (~$125K).
- · Chief Financial Officer FOSTER JEFFREY H acquired 396,875 Class B Ordinary Shares at $0.01 (~$1.98K)
- · Chief Financial Officer FOSTER JEFFREY H acquired 125,000 Private Placement Warrants (Right to Buy) at $1.00 (~$125K)
07-07-2026
Director FARSAI MALEA reported beneficial ownership in NETSOL TECHNOLOGIES INC. 1 position reported.
- · Holds 39,811 Common Stock (direct)
07-07-2026
Principal Accounting Officer Tray Thomas had withheld for taxes 477 Common Stock at $116.86 (~$55.7K). Tray Thomas holds 20,655 shares after the transaction.
- · Principal Accounting Officer Tray Thomas had withheld for taxes 477 Common Stock at $116.86 (~$55.7K)
07-07-2026
Chief Executive Officer Meury William had withheld for taxes 4,779 Common Stock at $116.86 (~$558K). Meury William holds 156,322 shares after the transaction.
- · Chief Executive Officer Meury William had withheld for taxes 4,779 Common Stock at $116.86 (~$558K)
07-07-2026
Executive Chair SAYER KEVIN R sold 26,756 Common Stock at $72.00 (~$1.93M). SAYER KEVIN R holds 355,726 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Executive Chair SAYER KEVIN R sold 26,756 Common Stock at $72.00 (~$1.93M)
07-07-2026
Chief Accounting Officer Nash Laura A. sold 260 Common Stock at $10.51 (~$2.73K). Nash Laura A. holds 10,770 shares after the transaction.
- · Chief Accounting Officer Nash Laura A. sold 260 Common Stock at $10.51 (~$2.73K)
07-07-2026
Director Teekell Judson Gray sold 3,000 Common Stock at $40.00 (~$120K). Teekell Judson Gray holds 75,251 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Teekell Judson Gray sold 3,000 Common Stock at $40.00 (~$120K)
07-07-2026
CMO & Head of Late-Stage Dev. Stein Steven H had withheld for taxes 2,177 Common Stock at $116.86 (~$254K). Stein Steven H holds 76,150 shares after the transaction.
- · CMO & Head of Late-Stage Dev. Stein Steven H had withheld for taxes 2,177 Common Stock at $116.86 (~$254K)
07-07-2026
EVP, Chief Commercial Officer McKechnie Duncan sold 1,541 Common Stock at $519.00 (~$800K). McKechnie Duncan holds 11,001 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · EVP, Chief Commercial Officer McKechnie Duncan sold 1,541 Common Stock at $519.00 (~$800K)
07-07-2026
Director Morris Matthew Shawn sold 59,037 Common Stock, par value $0.01 per share at $27.33 (~$1.61M). 6 transactions reported in total. Morris Matthew Shawn holds 68,188 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Morris Matthew Shawn exercised/converted 59,037 Common Stock, par value $0.01 per share at $2.00 (~$118K)
- · Director Morris Matthew Shawn sold 59,037 Common Stock, par value $0.01 per share at $27.33 (~$1.61M)
- · Director Morris Matthew Shawn exercised/converted 53,722 Common Stock, par value $0.01 per share at $2.00 (~$107K)
- · Director Morris Matthew Shawn sold 53,722 Common Stock, par value $0.01 per share at $27.24 (~$1.46M)
- · Director Morris Matthew Shawn exercised/converted 59,037 Stock Option (Right to Purchase)
- · Director Morris Matthew Shawn exercised/converted 53,722 Stock Option (Right to Purchase)
07-07-2026
President & CEO Meyrath Hugues sold 6,232 Common Stock at $10.51 (~$65.5K). Meyrath Hugues holds 118,468 shares after the transaction.
- · President & CEO Meyrath Hugues sold 6,232 Common Stock at $10.51 (~$65.5K)
07-07-2026
Director Eckert Kurt M. sold 5,250 Common Stock at $39.35 (~$207K). Eckert Kurt M. holds 149,612 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Eckert Kurt M. exercised/converted 5,250 Common Stock at $12.00 (~$63K)
- · Director Eckert Kurt M. sold 5,250 Common Stock at $39.35 (~$207K)
- · Director Eckert Kurt M. exercised/converted 5,250 Stock Option (Right to Buy)
07-07-2026
Director Skerjanec Simona was awarded 25,370 Stock Option.
- · Director Skerjanec Simona was awarded 25,370 Stock Option
Get daily alerts with 11 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Insider Trading Pulse
🇺🇸 More from United States
View all →July 07, 2026
US Pre-Market SEC Filings Roundup — July 07, 2026
US Pre-Market SEC Filings Roundup
July 07, 2026
Global High-Priority Regulatory Events — July 07, 2026
Global High-Priority Regulatory Events
July 07, 2026
USA Insider Trading Pulse — July 07, 2026
USA Insider Trading Pulse
July 07, 2026
US Corporate Distress Financial Stress SEC Filings — July 07, 2026
US Corporate Distress Financial Stress SEC Filings